Fulcrum Therapeutics, Inc. (FULC)
14.59
+1.60
(+12.32%)
USD |
NASDAQ |
Dec 09, 16:00
14.55
-0.04
(-0.27%)
After-Hours: 20:00
Fulcrum Therapeutics Total Liabilities (Quarterly): 16.49M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Agios Pharmaceuticals, Inc. | 101.38M |
| Biogen, Inc. | 11.00B |
| CorMedix, Inc. | 376.73M |
| Apellis Pharmaceuticals, Inc. | 657.56M |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 214.86M |
| Shareholders Equity (Quarterly) | 198.37M |
| Debt to Equity Ratio | 0.0353 |
| Current Ratio | 17.70 |
| Net Debt Paydown Yield | 0.11% |